ClinicalTrials.govpublic full text
Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML
core binding factor acute myeloid leukemia, sorafenib, cmr (complete molecular remission), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858324
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.